What is the recommended dosage for Cerefolin (L-methylfolate, vitamin B12, and vitamin B6)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cerefolin Dosage Recommendations

The recommended dosage for Cerefolin (L-methylfolate, vitamin B12, and vitamin B6) is typically 1 tablet daily, which contains L-methylfolate (5.6 mg), methylcobalamin (2 mg), and vitamin B6 (35 mg).

Components and Standard Dosages

Cerefolin is a medical food product containing three primary components:

  • L-methylfolate: 5.6 mg (the active form of folate)
  • Methylcobalamin (B12): 2 mg
  • Pyridoxine (B6): 35 mg

Clinical Context and Rationale

The dosage recommendation is based on several key factors:

  • Vitamin B12: The FDA label indicates that 1 mg per day may result in hematologic remission in patients with vitamin B12 deficiency 1. Cerefolin contains 2 mg of methylcobalamin, which exceeds this minimum effective dose.

  • Vitamin B6: Standard adult dosing for vitamin B6 is typically 1.3-1.7 mg daily according to RDA guidelines 2, with therapeutic doses ranging higher. The 35 mg in Cerefolin falls within safe therapeutic ranges, as the tolerable upper intake level is 100 mg/day 2.

  • L-methylfolate: The recommended dietary allowance for folate is 400 μg daily for adults 2, but therapeutic doses for hyperhomocysteinemia are typically higher. The 5.6 mg in Cerefolin is within the safe range, as the tolerable upper intake level is 1000 μg (1 mg) from fortified foods and supplements 2.

Special Considerations

Hyperhomocysteinemia

  • Cerefolin is often prescribed for patients with hyperhomocysteinemia
  • Research suggests that this combination therapy may help delay cortical and white matter atrophy in Alzheimer's disease and cerebrovascular disease 3

Renal Impairment

  • For patients on hemodialysis, standard doses of folate (1-5 mg) have been shown to be insufficient to normalize homocysteine levels 4
  • Higher doses or alternative approaches may be necessary in renal failure

Neurological Conditions

  • In patients with neurological symptoms due to vitamin B12 deficiency, oral high-dose vitamin B12 (1-2 mg daily) has been shown to be as effective as intramuscular administration 5

Safety Profile

  • Vitamin B12: No upper limit has been established due to low toxicity 2
  • Vitamin B6: Doses exceeding 100 mg/day may cause sensory neuropathy 2
  • Folate: Upper limit is 1000 μg/day from fortified foods and supplements 2, though therapeutic doses may exceed this under medical supervision

Monitoring Recommendations

  • For patients with suspected deficiencies, follow-up testing within 3 months after supplementation is recommended to verify normalization 6
  • For patients with ongoing risk factors, folate and B12 status should be measured every 3 months until stabilization, then annually 2

Important Cautions

  • Never administer folic acid before treating B12 deficiency, as this may mask hematologic manifestations while allowing neurological damage to progress 6, 1
  • Patients should be informed that if they have pernicious anemia, oral supplementation alone may be insufficient, and they may require monthly B12 injections 1

Remember that while Cerefolin is typically taken as one tablet daily, dosage adjustments may be necessary based on specific clinical circumstances and laboratory monitoring.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.